Effect of Osvalin and Piascladine on the treatment of knee osteoarthritis

Phase 3

• Conditions: knee osteoarthritis.; Arthrosis, unspecified; M19-9

• Registration Number: IRCT20180316039112N2
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

Patients with knee osteoarthritis

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: Measuring the pain at the beginning of the study (before the intervention) and 4, 8 and 12 weeks after starting the drug. Method of measurement: Visual Analogue Scale.